Jump to content

Definition:Comparable company analysis

From Insurer Brain

📈 Comparable company analysis is a valuation methodology widely used in insurance M&A, equity research, and IPO pricing that estimates the value of an insurance company by benchmarking it against publicly traded peers with similar business characteristics. Often called "trading comps" or "peer analysis," the approach relies on the principle that companies operating in comparable lines of business, geographies, and risk profiles should trade at broadly similar multiples of key financial metrics. In insurance, the relevant multiples differ from those used in many other industries: price-to-book value (P/BV), price-to-earnings (P/E), and price-to- tangible book value are the workhorses, supplemented by metrics such as price-to- embedded value for life insurers and multiples of gross written premium for high-growth or distribution-oriented businesses like MGAs.

⚙️ Constructing a meaningful comparable set in insurance requires careful attention to business mix, risk profile, and accounting framework. A specialty E&S carrier should not be compared uncritically to a large multiline personal-lines writer, even if both are classified as property-casualty insurers, because their growth rates, combined ratios, return on equity, and capital intensity differ fundamentally. Geographic and regulatory context also matters: a European insurer reporting under IFRS 17 may present different earnings patterns than a U.S. peer reporting under US GAAP, making direct multiple comparisons less straightforward without adjustments. Analysts typically compile a peer universe, calculate the relevant multiples for each company, derive a central tendency (median or mean), and then apply those multiples to the target company's financials — often with premiums or discounts to reflect qualitative differences such as franchise value, management quality, or underwriting track record. For reinsurers, Bermuda-domiciled specialists, and Lloyd's vehicles, dedicated peer groups have developed over time, each with its own valuation conventions.

🎯 The practical value of comparable company analysis lies in its market-grounded objectivity — it anchors valuation in what investors are actually willing to pay for similar businesses, rather than relying solely on intrinsic discounted cash flow models that depend on long-range assumptions about loss development and investment returns. In insurance M&A transactions, investment banks routinely present comps alongside precedent transaction analysis and actuarial appraisal values to triangulate a fair price range. The method is equally important for insurtech companies seeking public listings, where the choice between insurance-sector comps and technology-sector comps can dramatically influence perceived valuation. Despite its usefulness, the approach has limitations: insurance companies are rarely perfect comparables, and periods of market dislocation — such as post-catastrophe hard markets or financial crises — can distort multiples in ways that obscure fundamental value.

Related concepts: